User Support Reference Group

Page tree

Meeting Details

Date & Time: 13th March 2025, 11am UTC (Online)

Objectives

  • Users' discussions about the SNOMED International Drug Model and National Drug Extension Model.

Attendees:


Zoom Link

Link: DEUSG 13th March 2025 Zoom Meeting Link

Meeting ID: 83531388789

Passcode: 076324

Meeting Recording

Link: https://snomed.zoom.us/rec/share/JlDMaz72eA0Gz6K7vBMYEoKknzobOd8gZY_erw7P24geux-F6cE7jYQ8cXYHtwAY.kzLqi4Kozkk5uvwv

Passcode: AH7s$SU7

Discussion items                                       

Item

Description

Mins

Owner

Notes & Actions

1Opening2

Shane Byrnes 

Welcome & Notification of Recording

2House Keeping2

Shane Byrnes 

Alejandro Lopez Osornio 

Group Feedback on Alternating time zones proposal: (World Time Buddy)

  • March 13th: 11am UTC (online)
  • April 9th: 1.30pm CEST / 11.30am UTC (online & in person)
  • May: 10pm UTC (online)
  • June: 11am UTC (online)
  • July: 10pm UTC (online)

Meeting Notes:

  • Alternating timelines to be trialed in the months ahead.
3Discussion Forum2

Shane Byrnes 

Discussion Forum has been set up.

  • To support community sharing of queries and updates between meetings.
  • Opportunity for community knowledge sharing on implementation. 
  • Use 'DEUSG' for Category.
  • Select 'Watch' on the Discussion Forum page to keep up to date.

Of Interest: SNOMED adding forum platform later this year ('Discourse')

Meeting Notes:

  • Nicki will post Patch strength briefing notes to the discussion forum to allow members to share further feedback. 
4Current status of the Drug Model and proposals for modifications30

Matt Cordell / Dion McMurtrie 

Linda Bird  / Guillermo Reynoso 

Continuation of Agenda Item from 20th Feb:

  • Australia Presentation
  • Follow on Information from Canada (use-cases)
  • Feedback to Irelands Proposal
    • How would approach manage salts in biosimilars or differences in SmPC documentation. 
  • Group Discussion/Comments on three proposals

Meeting Notes:

  • Group discussion Australia's and Canada's presentations: covering strength representation, subsumption of Clinical Drugs, and additional properties


5Substances - Concepts in Extensions5Alejandro Lopez Osornio
  • Work underway to collate list across extensions (MS and non-MS)

Meeting Notes:

  • Thanks to all members who submitted lists. 
6Substances - authoring for medicines under evaluation (EMA)2

Shane Byrnes 

Alejandro Lopez Osornio 

Meeting Notes:

  • No Update
7Group discussion - Forum queries10All

Feedback on forum questions:

  • RxNorm - SNOMED Alignment

Meeting Notes:

  • Item deferred to April meeting
8Oslo Preparation2Shane Byrnes 

Seeking proposals for agenda items in Oslo

Meeting Notes:

  • Members to reach out to Alejandro and Shane to propose topics for April meetings
9General Community Updates2

Alejandro Lopez Osornio Shane Byrnes 

Open Briefing Note

Inactivation of Active Duplicate Descriptions in the Same Hierarchy

  • Relevant to Drug Modelling: basic dose form etc.
  • Link to Briefing Note on Confluence HERE
  • Feedback by 31st March 2025 to Maria Braithwaite via info@snomed.org


Expo 2025 - Call for Abstracts is Open

  • SNOMED CT Expo | SNOMED International
  • Call for abstracts is open until 24th April 2025
  • Outcome of submissions by 31st May 2025
  • Call open for Session Presentations, 10min Lightening Talks, or ePosters
10AOB2



  File Modified
PNG File image-2025-2-28_17-56-43.png 2025-Feb-28 by Shane Byrnes
PDF File DEUSG - AMTv4 – Why we deviated.pdf 2025-Mar-13 by Shane Byrnes